Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Evogene Ltd Ord (EVGN)

1.28   0.23 (21.9%) 06-03 16:00
Open: 1.09 Pre. Close: 1.05
High: 1.48 Low: 1.06
Volume: 828,665 Market Cap: 32M
Evogene Ltd is a biotechnology company for the improvement of crop productivity. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.481 - 1.492 1.492 - 1.5
Low: 1.046 - 1.054 1.054 - 1.06
Close: 1.267 - 1.282 1.282 - 1.294

Technical analysis

as of: 2020-06-03 4:29:06 PM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.73     One year: 2.02
Support: Support1: 1.18    Support2: 0.99
Resistance: Resistance1: 1.48    Resistance2: 1.73
Pivot: 1.09
Moving Average: MA(5): 1.10     MA(20): 1.10
MA(100): 1.23     MA(250): 1.42
MACD: MACD(12,26): 0.01     Signal(9):
Stochastic oscillator: %K(14,3): 43.06     %D(3): 32.80
RSI: RSI(14): 64.46
52-week: High: 1.83  Low: 0.75  Change(%): -15.2
Average Vol(K): 3-Month: 3120  10-Days: 10013

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
EVGN has closed Bollinger Bands are 26.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 14 Nov 2018
Evogene Reports Third Quarter 2018 Financial Results Nasdaq:EVGN - GlobeNewswire

Mon, 19 Nov 2018
Evogene Announces Establishment of Ag-Chemicals Subsidiary – AgPlenus Ltd. - GlobeNewswire

Tue, 28 Mar 2017
Marrone Bio Innovations and Evogene Advance Novel Bacteria and Related Proteins Beyond Discovery into Insecticidal Product Development Phase - GlobeNewswire

Tue, 18 Dec 2018
Evogene and TMG Announce Collaboration to Develop Nematode Resistant Soybean through Genome Editing - GlobeNewswire

Fri, 22 May 2020
Westell Technologies - Consensus Indicates Potential 47.6% Upside - DirectorsTalk Interviews

Thu, 21 May 2020
Infrastructure and Energy Alter - Consensus Indicates Potential 65.7% Upside - DirectorsTalk Interviews

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 26
Shares Float (M) 23
% Held by Insiders 12.33
% Held by Institutions 28.37
Shares Short (K) 74
Shares Short P. Month (K) 40

Stock Financials

EPS -0.703
EPS Est This Year -0.710
EPS Est Next Year -0.350
Book Value (p.s.) 1.950
Profit Margin
Operating Margin -2810.89
Return on Assets (ttm) -20.3
Return on Equity (ttm) -34.6
Qtrly Rev. Growth -81.7
Gross Profit (p.s.) 0.016
Sales Per Share 0.029
EBITDA (p.s.) -0.744
Qtrly Earnings Growth
Operating Cash Flow (M) -18
Levered Free Cash Flow (M) -12

Stock Valuations

PE Ratio -1.82
PEG Ratio
Price to Book value 0.66
Price to Sales 43.77
Price to Cash Flow -1.87

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.